Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. develops artificial intelligence and neural-network technology for digital health applications. The company’s platforms use signal processing and deep learning to convert biometric data into clinical insights, with recurring updates centered on ECG analysis, heart rate variability analytics, remote cardiac monitoring, and cardiovascular research support.
News for AIMLF also covers activity at its Neural Cloud Solutions subsidiary, including MaxYield™, CardioYield™, and Insight 360™ commercialization, reseller and distribution agreements, research-services collaborations, medical advisory board appointments, and capital-structure actions such as private placements, convertible debentures, warrants, options, and share issuances for debt settlement.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has introduced Health Coach, an AI-powered personal health advisor developed by its subsidiary Health Gauge Inc. This innovative system facilitates users to set personalized health goals and receive tailored care recommendations by analyzing their health data. User trials are set to begin shortly, with a full service subscription version planned for release later this year. Initially, Health Coach will be offered for free to select users, with limited interaction capabilities. Its unique design addresses the 'hallucination problem' seen in other AI systems by ensuring accurate information delivery. Health Coach aims to complement healthcare professionals and has potential for significant disruption in the healthcare industry by leveraging AI technology to enhance patient care.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced that its subsidiary, Tech2Heal, will serve as the technology partner for Europe's largest study focused on preventing loss of autonomy in the elderly. The study, led by the University Hospital of Nice, France, will involve 30,000 patients and aims to provide personalized care pathways. Tech2Heal's Alakin Platform will facilitate data collection, patient engagement, and customized clinical trials. With over 100 million Europeans aged 65 or older, this initiative highlights the market potential for innovative healthcare solutions targeting aging populations. CEO Fabrice Pakin emphasizes the promising revenue streams from such projects.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) has announced a marketing services agreement with Frontier Flex Marketing Group to enhance public exposure over 12 months, compensating Frontier $96,000. The company has also issued 1,000,000 stock options to management at an exercise price of $0.20 for five years, pending regulatory approvals. AI/ML Innovations focuses on artificial intelligence and machine learning within digital health, with significant stakes in Health Gauge (100% ownership), Tech2Heal (22% potential ownership), and AI Rx Inc. (70% ownership). The company aims to advance transformative healthcare solutions.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has updated its previous announcement regarding a non-brokered private placement. The Company accepted subscriptions for 4,867,748 units at a price of $0.06 per unit, bringing gross proceeds to $292,064.88, lower than the earlier stated 5,086,498 units. AI/ML continues to focus on investments in artificial intelligence (AI) and machine learning (ML), particularly in digital health and wellbeing sectors. The Company holds strategic partnerships, including a 70% ownership in Health Gauge and AI Rx Inc., which aim to enhance healthcare solutions.